In the BioHarmony Drug Report Database
Balsalazide
Colazal, Giazo (balsalazide) is a small molecule pharmaceutical. Balsalazide was first approved as Colazal on 2000-07-18. It is used to treat ulcerative colitis in the USA. Colazal’s patents are valid until 2031-06-23 (FDA).
Trade Name
|
Colazal, Giazo |
|---|---|
Common Name
|
balsalazide |
ChEMBL ID
|
CHEMBL1201346 |
Indication
|
ulcerative colitis |
Drug Class
|
Anti-inflammatory agents (salicylic acid derivatives) |
Image (chem structure or protein)